Oncology “Off-the-Shelf” Treatment Options in Relapsed/Refractory Diffuse Large B-Cell Lymphoma patient care perspectives By Brad Kahl, MD
Oncology CD19-Directed Therapies and Antibody-Drug Conjugates for Relapsed/Refractory Diffuse Large B-Cell Lymphoma clinical topic updates By Brad Kahl, MD
Oncology Targeted Therapy for Metastatic Castration-Resistant Prostate Cancer: Organized Approach to Genomic Evaluation expert roundtables By Daniel J. George, MD; Oliver Sartor, MD; Peter R. Carroll, MD, MPH
Oncology Treatment Sequencing in Patients With Castration-Resistant Prostate Cancer expert roundtables By Daniel J. George, MD; Oliver Sartor, MD; Peter R. Carroll, MD, MPH
Psychiatry Reducing Cardiometabolic Risk in Patients With Serious Psychiatric Illness expert roundtables By John M. Kane, MD; Jonathan M. Meyer, MD; Leslie Citrome, MD, MPH